GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options, underscoring the need for novel therapeutic targets. Metabolic reprogramming is a hallmark of PDAC, enabling tumor cells to sustain rapid proliferation and survive under nutrient-deprived conditions. Whil...
Saved in:
| Main Authors: | Jenna N. Duttenhefner, Katie M. Reindl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Molecular & Cellular Oncology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/23723556.2025.2518773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Parameters of the glutathione system and thioredoxin in blood plasma and ascites and GSTP1 Ile105Val gene polymorphism as factors of resistance to platinum-containing chemotherapy in ovarian cancer patients
by: D. R. Dolgova, et al.
Published: (2021-01-01) -
JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis
by: Yuwan Zhao, et al.
Published: (2025-05-01) -
A case of pancreatic head cancer with Trousseau’s syndrome treated with radical resection and anticoagulant therapy
by: Takumi Kitahama, et al.
Published: (2023-01-01) -
Lipid metabolism reprograming by SREBP1‐PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy
by: Mengyi Lao, et al.
Published: (2025-08-01) -
Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)